Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Tarun Mullick

Gastroenterology Chandler, AZ Medical Doctor

NPI 1912906462 CMS profile 313366

485 S Dobson Rd Ste 101, Chandler, AZ 85224

Open in the dashboard

General payments

$60,607

192 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Tarun Mullick of Chandler, AZ is reported in the CMS Open Payments database as having received $60,607 across 192 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $145 1
2024 General $23 1
2023 General $3,074 5
2022 General $2,259 10
2021 General $7,289 34
2020 General $6,771 19
2019 General $41,046 122

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tarun Mullick
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to Tarun Mullick were reported at $145. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year Tarun Mullick Gastroenterology median Middle half National median
2019 $41,046 $417 $126–$1,100 $163
2020 $6,771 $224 $74–$624 $114
2021 $7,289 $352 $106–$1,054 $132
2022 $2,259 $448 $129–$1,270 $149
2023 $3,074 $533 $150–$1,390 $160
2024 $23 $605 $160–$1,606 $164
2025 $145 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Allergan Inc. $41,611 86 payments
  2. Nestle HealthCare Nutrition Inc. $17,338 18 payments
  3. AbbVie, Inc. $396 16 payments
  4. Gilead Sciences, Inc. $292 16 payments
  5. UCB, Inc. $163 13 payments
  6. Pfizer Inc. $151 13 payments
  7. Mallinckrodt Hospital Products Inc. $145 1 payment
  8. Janssen Biotech, Inc. $122 7 payments
  9. Intercept Pharmaceuticals, Inc. $89 5 payments
  10. Ferring Pharmaceuticals Inc. $82 5 payments
  11. Other $219 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $46,825 36 payments
  2. Travel and Lodging $11,146 33 payments
  3. Food and Beverage $2,554 118 payments
  4. Consulting Fee $75 4 payments
  5. Education $7 1 payment
Products named General payments · program years 2019–2025
  1. ZENPEP Cystic Fibrosis $21,939 34 payments
  2. ZENPEP Endocrine Pancreatic Insufficiency $17,338 18 payments
  3. LINZESS $13,393 43 payments
  4. VIBERZI $6,393 15 payments
  5. CREON $297 11 payments
  6. Cimzia $163 13 payments
  7. XELJANZ $151 13 payments
  8. TERLIVAZ $145 1 payment
  9. STELARA $122 7 payments
  10. Epclusa $120 1 payment
  11. Other $518 29 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 43 billing codes

Paid by Medicare

$64,172

Medicare's payments for the services billed

Medicare patients

277

Average age 75

Services billed

683

134 women, 143 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 48%
Chronic kidney disease 46%
Diabetes 45%
Ischemic heart disease 44%
Heart failure 43%
Atrial fibrillation 39%
Depression 37%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

192 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record